Core Viewpoint - The company, Jinfa Labi Maternal and Child Products Co., Ltd., has issued a profit warning for the fiscal year 2025, anticipating a negative net profit due to various operational challenges and investment losses [1][3]. Group 1: Performance Forecast - The performance forecast period is from January 1, 2025, to December 31, 2025, with an expected net profit in negative territory [1]. - The company projects a revenue contribution of approximately 68 million yuan from the acquisitions of Zhuhai Hanfei and Zhongshan Hanfei in 2025 [2]. - The company aims to expand its product line and online channels, transitioning from maternal and infant products to family fast-moving consumer goods, which is expected to drive revenue growth [2]. Group 2: Profit Variability Reasons - The primary reason for the anticipated profit decline is the ongoing losses from the associated company, Guangdong Hanfei Hospital Investment Co., Ltd., which will require the company to recognize investment losses and provision for long-term equity investment impairment in 2025 [3]. Group 3: Arbitration and Legal Matters - The company has initiated arbitration against Guangzhou Wenmei Enterprise Management Consulting Partnership and Huang Zhaobiao for the repurchase of a 36% stake in Guangdong Hanfei Hospital Investment Co., Ltd., along with a claim for approximately 318.38 million yuan in repurchase payments [16]. - As of the announcement date, the respondents have not fulfilled their repurchase obligations, prompting the company to file for enforcement with the Guangzhou Intermediate People's Court [17].